Source: International Congress 2015 – New insights into lung disease pathogenesis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Eleni Papakonstantinou (Thessaloniki, Greece), Eleni Papakonstantinou, Ioannis Bonovolias, Michael Roth, Michael Tamm, Lucas Boeck, Andreas Scherr, Janko Rakic, Renaud Louis, Branislava Milencovic, Wim Boersma, Konstantinos Kostikas, Francesco Blasi, Ioachim Aerts, Gernot Rohde, Alicia Lacoma, Antoni Torres, Tobias Welte, Daiana Stolz. Hyaluronic acid is associated with survival time in stable COPD independently of exacerbation rate, BODE index and adjusted Charlson score. Eur Respir J 2015; 46: Suppl. 59, 868

Member's Comments

No comment yet.

Related content which might interest you: Change in BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Higher BODE Index in COPD patients correlated with higher number of comorbidities Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Fatigue in COPD: association with functional status and hospitalisations Source: Eur Respir J 2013; 41: 565-570 Year: 2013 The modified BODE index: validation with mortality in COPD Source: Eur Respir J 2008; 32: 1269-1274 Year: 2008 Significance of quantitative radiological phenotypes of COPD on BODE index Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 BODE index as predictor of exacerbation occurrence in ambulatory patients with COPD Source: Annual Congress 2007 - Exacerbations of COPD Year: 2007 COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 The derivation of a new index of severity for COPD patients, the DOSE index: MRC dyspnea scale, airflow obstruction, smoking status and exacerbations Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation Year: 2007 BODCAT index: Could we use it instead of BODE or BODEx to classify COPD severity? Source: International Congress 2014 – Clinical presentations Year: 2014 Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV1 predict treatment failure during hospitalisation due to COPD exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 525s Year: 2007 The value of short physical performance battery (SPPB) as an alternative component of the BODE Index in predicting death in chronic obstructive pulmonary disease (COPD) in the ERICA cohort. Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018 What is the best predictor of mortality in chronic obstructive pulmonary disease? (BODE index and CPET) Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Assessment the dependence between nutritional status and functional damage of the lungs as well as prognosis in BODE index in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 A Comparison of three severity assessment scores: APACHI II SOFA and CURB 65 for predicting inpatient mortality in patients with acute exacerbation of COPD (AECOPD) Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning Year: 2015 Modified pulmonary index score (MPIS) and indication of hospitalization for acute asthma exacerbation in children Source: International Congress 2016 – Techniques and tools in paediatric asthma Year: 2016 Impact of disease severity and comorbidities on length of stay (LOS) in COPD Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 Dyspnoea, obstruction, smoking and exacerbation (DOSE) index and mortality in COPD Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes Year: 2011 The index distance-saturation product like predicting of mortality in patients with COPD Source: Annual Congress 2008 - Exercise intolerance: mechanism, intervention and assessment Year: 2008